MYOS RENS Technology Inc.
45 Horsehill Road
About MYOS RENS Technology Inc.MYOS RENS is dedicated to developing innovative products that improve muscle mass, increase mobility and reduce frailty. MYOS RENS is a biotherapeutics and bionutrition company focused on the discovery, development and commercialization of products that improve human muscle health and performance.
Please click here for clinical trial information.
28 articles with MYOS RENS Technology Inc.
MYOS RENS Technology Announces Initiation of a Study at Kansas State University to Evaluate the Impact of Fortetropin® on Quality of Life and Activity in Geriatric Dogs
MYOS RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), an advanced nutrition company and the owner of Fortetropin®, a proprietary bioactive composition derived from fertilized egg yolk that helps build lean muscle, announced that it has signed an agreement with Kansas State University College of Veterinary Medicine
MYOS RENS Technology Inc. announced an endorsement partnership with NBA superstar Aaron Gordon of the Orlando Magic.
MYOS CEO Joseph Mannello Issues Letter to Shareholders Following Presentation at North American Veterinary Community (NAVC) Conference/VMX
Fortetropin's Benefits Demonstrated in Canine Recovery from Joint Surgery
MYOS RENS Technology Announces Study Results Demonstrating Fortetropin®, the Active Ingredient in Myos Canine Muscle Formula, Prevents Muscle Loss in Canines After Surgery and Enhances Recovery
Positive Results Obtained from Kansas State University Study
MYOS RENS Technology Announces Upcoming Presentation of Results from a Kansas State University Study Evaluating the Impact of Fortetropin® on Canine Muscle Loss after Surgery, at a Major Veterinary Conference, January 20, 2019
Results Relevant to Company's Veterinary and Human Nutrition Business
New Patent Will Significantly Enhance its Fortetropin® Intellectual Property Portfolio
MYOS RENS Technology Inc. issued the following letter to shareholders from MYOS CEO Joseph Mannello
ERIC ZALTAS JOINS BOARD OF DIRECTORS
MYOS RENS Technology Launches 'Yolked®', Its Sports Nutrition Product, With The Vitamin Shoppe® Nationwide
MYOS RENS Technology Inc. announced today that The Vitamin Shoppe® will distribute MYOS' muscle-enhancing sports nutrition product line, 'Yolked®' formulated with Fortetropin®.
Net Proceeds of $1.1 Million in Non-dilutive Funding Expected
MYOS RENS Technology Signs Distribution Agreement With Miller Veterinary Supply East To Bring Innovative MYOS Canine Muscle Formula™ To 6,000+ Veterinary Hospitals
First Distribution Agreement for MYOS Canine Muscle Formula™
MYOS RENS Technology Announces The Date For The Release Of Third Quarter 2018 Results, Conference Call And Webcast
MYOS RENS Technology Inc. announced today that it will provide financial results for the third quarter of 2018 on Tuesday, November 13 after the market closes.
MYOS RENS Technology To Exhibit MYOS Canine Muscle Formula™ At The Atlantic Coast Veterinary Conference, October 8-11, 2018
MYOS RENS Technology Inc. announced today that MYOS will exhibit at the Atlantic Coast Veterinary Conference in Atlantic City, NJ, from October 8-11, 2018.
MYOS RENS Technology Inc., a bionutrition company and owner of Fortetropin®, the natural food product that helps build lean muscle in conjunction with resistance training, announced today its financial results for the three months and six months ended June 30, 2018.
MYOS RENS Technology Announces The Date For The Release Of Second Quarter And First Half 2018 Results, Conference Call And Webcast
MYOS RENS Technology Inc. announced that it will announce financial results for the second quarter and first half of 2018 on Wednesday, August 8 after the market closes.
MYOS RENS Technology Launches Advanced Veterinary Supplement Product For Dogs, Powered By Fortetropin®
ENTERS INTO THE $500 MILLION U.S. PET SUPPLEMENTS MARKET PRODUCT DEVELOPED TO SUPPORT MUSCLE HEALTH IN DOGS
Correction on the news release, MYOS RENS Technology Announces the Date for the Release of First Quarter 2018 Results, Conference Call and Webcast, issued 03-May-2018 by MYOS RENS Technology Inc.
MYOS RENS Technology Introduces New Sports Nutrition Product Line, Yolked™, and Earns Prestigious "Certified For Sport®" Certification From NSF International
NSF "Certified for Sport®" Certification Further Demonstrates MYOS' Commitment To Providing Safe, Quality Products
MYOS RENS Technology to Present at the MicroCap Conference April 10 in New York City at the Essex House
MYOS RENS Technology Inc. announced that the Company's Chief Executive Officer, Joseph Mannello, will present at the MicroCap Conference on Tuesday, April 10th at 12:30 p.m. Eastern Time at the Essex House in New York City.
The CEO of MYOS RENS Technology Joseph Mannello, issued the following letter to shareholders.